SEARCH

SEARCH BY CITATION

Reference

  • MERCK (1962). J. Am. Med. Ass., 179, 717718.
  • Ala-Hurula, V., Myllylä, V.V., Hokkanen, E. & Tokola, O. (1981). Tolfenamic acid and ergotamine abuse. Headache, 21, 240242.
  • Anthony, M. (1981). Biochemical indices of sympathetic activity in migraine. Cephalalgia, 1, 8389.
  • Curran, D. A., Hinterberger, H. & Lance, J. W. (1965). Total plasma serotonin, 5-hydroxyindole-acetic acid and p-hydroxy-m-methoxymandelic acid excretion in normal and migrainous subjects. Brain, 88, 9971010.
  • Graffner, C., Lagerström, P-O., Lundborg, P. & Rönn, O. (1979). Pharmacokinetics of metoclopramide intravenously and orally determined by liquid chromatography. Br. J. clin. Pharmac., 8, 469474.
  • Hakkarainen, H., Parantainen, J., Gothoni, G. & Vapaatalo, H. (1982). Tolfenamic acid and caffeine: A useful combination in migraine. Cephalalgia, 2, 173177.
  • Hakkarainen, H., Vapaatalo, H., Gothoni, G. & Parantainen, J. (1979). Tolfenamic acid is as effective as ergotamine during migraine attacks. Lancet, ii, 326328.
  • Harrington, R. A., Hamilton, C. W., Brogden, R. N., Linkewich, J. A., Romankiewicz, R. A. & Heel, R.C. (1983). Metoclopramide. An updated review of its pharmacological properties and clinical use. Drugs, 25, 451494.
  • Hsu, L. K. G., Crisp, A. H., Kalucy, R. S., Koval, J., Chen, C. N., Carruthers, M. & Zilkha, K. J. (1978). Nocturnal plasma levels of catecholamines, tryptophan, glucose, and free fatty acids and the sleeping encephalographs of subjects experiencing early morning migraine. In Current Concepts in Migraine Research, ed. Greene, R. pp. 121130. New York: Raven Press..
  • Joyce, C. R. B., Zutshi, D. W., Hrubes, V. & Mason, R. M. (1975). Comparison of fixed interval and visual analogue scales for rating chronic pain. Eur. J. clin. Pharmac., 8, 415420.
  • Lance, J. W., Anthony, M. & Hinterberger, H. (1967). The control of cranial arteries by humoral mechanisms and its relations to the migraine syndrome. Headache, 7, 93102.
  • Linden, I-B., Parantainen, J. & Vapaatalo, H. (1976). Inhibition of prostaglandin bioasynthesis by tolfenamic acid in vitro. Scand. J. Rheumatol., 5, 129132.
  • Malagelada, J-R. (1982). Gastric emptying disorders. Clinical significance and treatment. Drugs, 24, 353359.
  • Manninen, V., Apajalahti, A., Melin, J. & Karesoja, M. (1973). Altered absorption of digoxin in patients given propantheline and metoclopramide. Lancet, I, 398400.
  • Mathew, R. J., Ho., B. T., Kralik, P., Taylor, D. & Claghom, J. L. (1980). Catecholamines and migraine: Evidence based on biofeedback induced changes. Headache, 20, 247252.
  • Maxwell, C. (1978). Sensitivity and accuracy of the visual analogue scale: A psychophysical classroom experiment. Br. J. clin. Pharmac., 6, 1524.
  • Mearrick, P. T., Wade, D. N., Birkett, D. J. & Morris, J. (1974). Metoclopramide, gastric emptying and L-dopa absorption. Aust. N.Z. J. Med., 4, 144148.
  • Nimmo, W. S. (1976). Drugs, diseases and altered gastric emptying. Clin. Pharmacokin., 1, 189203.
  • Nimmo, W. S. (1981). Gastric emptying and drug absorption. In Drug absorption, eds Prescott, L. F. & Nimmo, W. S., pp. 1120. New York: Adis Press..
  • Pentikäinen, P. J., Neuvonen, P. J. & Backman, C. (1981). Human pharmacokinetics of tolfenamic acid, a new anti-inflammatory agent. Eur. J. clin. Pharmac., 19, 359365.
  • Pinder, R. M., Brogden, R. N., Sawyer, P. R., Speight, T. M. & Avery, G. S. (1976). Metoclopramide: A review of its pharmacological properties and clinical use. Drugs, 12, 81131.
  • Prescott, L. F. (1974). Gastric emptying and drug absorption. Br. J. clin. Pharmac., 1, 189190.
  • Rees, M. R., Clark, R. A. & Holdsworth, C. D. (1980). The effect of β-adrenoceptor agonists and antagonists on gastric emptying in man. Br. J. clin. Pharmac., 10, 551554.
  • Ross-Lee, L., Heazlewood, V., Tyrer, J.H. & Eadie, M.J. (1982). Aspirin treatment of migraine attacks: plasma drug level data. Cephalalgia, 2, 914.
  • Schulze-Delrieu, K. (1981). Metoclopramide. New Engl. J. Med., 305, 2833.
  • Tokola, R. A., Anttila, V-J. & Neuvonen, P. J. (1982). The effect of metoclopramide on the absorption of tolfenamic acid. Int. J. clin. Pharmac. Ther. Tox., 20, 465468.
  • Tokola, R. A. & Neuvonen, P.J. (1981). Absorption of effervescent paracetamol during migraine. Acta Pharmac. Tox., 49, (Suppl. 1), 78.
  • Vapaatalo, H., Parantainen, J., Lindén, I-B. & Hakkarainen, H. (1977). Prostaglandins and vascular headache. Action of tolfenamic acid, a new anti-inflammatory analgesic, on migraine. In Headache: New Vistas, ed. Sicuteri, F. pp. 287300. Florence (Italy): Biochemical Press..
  • Volans, G. N. (1974). Absorption of effervescent aspirin during migraine. Br. med. J., 4, 265269.
  • Volans, G. N. (1975). The effect of metoclopramide on the absorption of effervescent aspirin in migraine. Br. J. clin. Pharmac., 2, 5763.
  • Volans, G. N. (1978). Research review. Migraine and drug absorption. Clin. Pharmacokin., 3, 313318.